When considering the whole cohort, we observed lower TRPV2 expression in stage 1 and stage 2 tumors, while higher TRPV2 expression was evident in more advanced tumor stages, specifically in stage 3 (Fig. 1F-G). Here, TRPV2 is linked to neoplasm.